Paper307998
Metabolism of intact and desialylated alpha 1-antitrypsin.
Jones EA and 4 others. Clin Sci Mol Med, 1978. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Metabolism of intact and desialylated alpha 1-antitrypsin. Papers, record 307998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/307998
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| alpha 1-Antitrypsin | Major topic |
| Adolescent | |
| Adult | |
| Female | |
| Half-Life | |
| Humans | |
| Iodine Radioisotopes | |
| Liver | |
| Male | |
| Sialic Acids |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33679157 | A new electrochemical impedance biosensor based on aromatic thiol for alpha-1 antitrypsin determination. | Turk J Chem | 2021 | https://conductscience.org/library/papers/33679157 | PubMed |
| 32764414 | Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy. | J Clin Med | 2020 | https://conductscience.org/library/papers/32764414 | PubMed |
| 29618937 | The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. | J Inflamm Res | 2018 | https://conductscience.org/library/papers/29618937 | PubMed |
| 25586483 | GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes. | Inflammation | 2015 | https://conductscience.org/library/papers/25586483 | PubMed |
| 12728289 | Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. | Eur J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12728289 | PubMed |
| 9638392 | Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers? | Drugs Aging | 1998 | https://conductscience.org/library/papers/9638392 | PubMed |
| 7028785 | Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7028785 | PubMed |
| 6975283 | A model of decreased functional alpha-1-proteinase inhibitor. Pulmonary pathology of dogs exposed to chloramine T. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6975283 | PubMed |
| 6967489 | Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6967489 | PubMed |
| 6085504 | Profiles of acute-phase reactants and clinical significance of alpha 2-macroglobulin in acute hepatitis B. | Inflammation | 1983 | https://conductscience.org/library/papers/6085504 | PubMed |
| 3552338 | Change in alpha 1-antitrypsin phenotype after orthotopic liver transplant. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3552338 | PubMed |
| 288065 | Selective hepatic uptake of human beta-hexosaminidase A by a specific glycoprotein recognition system on sinusoidal cells. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/288065 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SERPINA1 | 5265 | PubTator's text mining | https://conductscience.org/library/genes/5265 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/307998
GET https://conductscience.org/api/papers/v1/307998/authors